Literature DB >> 12043949

Hawthorn.

Qi Chang1, Zhong Zuo, Francisco Harrison, Moses Sing Sum Chow.   

Abstract

A review with 54 references covers all aspects of hawthorn, the genus Crataegus, including its traditional uses, chemical constituents, pharmacological activities, and clinical effects. Although the effectiveness of hawthorn on the treatment of cardiovascular diseases has received extensive attention worldwide, further scientific research on various areas such as pharmacokinetics, mechanism of actions will be necessary to ensure its safe and effective usage.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12043949     DOI： 10.1177/00970002042006003

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


  37 in total

1.  Randomised, double-blind, placebo-controlled, assessment of the efficacy and safety of dietary supplements in prehypertension.

Authors:  F Pelliccia; V Pasceri; G Marazzi; A Arrivi; L Cacciotti; G Pannarale; G Speciale; C Greco; C Gaudio
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

2.  Crataegus mexicana (Tejocote) Exposure Associated with Cardiotoxicity and a Falsely Elevated Digoxin Level.

Authors:  Katherine G Palmer; Jacob A Lebin; Michael T Cronin; Suzan S Mazor; Rebekah A Burns
Journal:  J Med Toxicol       Date:  2019-08-12

3.  Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats.

Authors:  Hassan Malekinejad; Vahid Shafie-Irannejad; Rahim Hobbenaghi; Seyed Hamed Tabatabaie; Seyed-Mehdi Moshtaghion
Journal:  J Med Food       Date:  2013-07       Impact factor: 2.786

4.  In Vitro Protection by Crataegus microphylla Extracts Against Oxidative Damage and Enzyme Inhibition Effects.

Authors:  Gülin Renda; Arzu Özel; Burak Barut; Büşra Korkmaz; Nurettin Yayli
Journal:  Turk J Pharm Sci       Date:  2018-04-02

Review 5.  Adverse-event profile of Crataegus spp.: a systematic review.

Authors:  Claudia Daniele; Gabriela Mazzanti; Max H Pittler; Edzard Ernst
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

6.  Validation of the Antidiabetic and Hypolipidemic Effects of Hawthorn by Assessment of Gluconeogenesis and Lipogenesis Related Genes and AMP-Activated Protein Kinase Phosphorylation.

Authors:  Chun-Ching Shih; Cheng-Hsiu Lin; Yih-Jiun Lin; Jin-Bin Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-16       Impact factor: 2.629

7.  Activity of hawthorn leaf and bark extracts in relation to biological membrane.

Authors:  Aleksandra Włoch; Ireneusz Kapusta; Krzysztof Bielecki; Jan Oszmiański; Halina Kleszczyńska
Journal:  J Membr Biol       Date:  2013-06-18       Impact factor: 1.843

8.  The combination of catechin and epicatechin callate from Fructus Crataegi potentiates beta-lactam antibiotics against methicillin-resistant staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  Rongxin Qin; Kangkang Xiao; Bin Li; Weiwei Jiang; Wei Peng; Jiang Zheng; Hong Zhou
Journal:  Int J Mol Sci       Date:  2013-01-16       Impact factor: 5.923

9.  Designing universal primers for the isolation of DNA sequences encoding Proanthocyanidins biosynthetic enzymes in Crataegus aronia.

Authors:  Afnan Saeid Zuiter; Jammal Sawwan; Ayed Al Abdallat
Journal:  BMC Res Notes       Date:  2012-08-10

10.  Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters.

Authors:  Yuguang Lin; Mario A Vermeer; Elke A Trautwein
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.